# Inne

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/inne

- Industry: Healthcare
- Headquarters: Berlin, Germany
- Website: www.inne.io
- Total disclosed funding: $19M
- Latest round: Series B (Feb 25, 2022)
- Investors on record: 7

## About

Inne is a Berlin-based company that specializes in at-home fertility monitoring, providing women with tools to track hormonal trends and menstrual cycles accurately.Founded in 2016 in Berlin, Germany, Inne focuses on innovative fertility solutions. The company has undergone no significant pivots and is led by CEO Eirini Rapti, who is also a co-founder alongside Jimmy Funkhouser. Inne raised EUR 9.3 million in a Series B funding round on February 25, 2022, led by DSM Venturing, along with other investors, bringing the total raised to EUR 9.3 million and achieving a current valuation of EUR 48.33 million.The company's core offering is the inne Minilab, an at-home fertility monitoring system that measures progesterone levels through saliva testing. This innovative device helps users track their menstrual cycles and identify fertile windows, empowering women with natural fertility tracking solutions. Accompanied by a comprehensive app, the inne Minilab provides personalized insights for women aged 18 and over, particularly those not pregnant or undergoing hormonal treatments, and is marketed primarily in European regions.Inne generates revenue primarily through direct-to-consumer subscriptions for its fertility tracking services. Customers can choose from subscription plans, including a 12-month package that provides monthly strips and the inne Reader for continuous monitoring. The pricing structure includes discounts for long-term subscriptions to enhance customer retention, with revenue stemming from these ongoing subscription services.Following their recent Series B funding of EUR 9.3 million, Inne plans to utilize these resources for medical research focused on women's health. The company aims to expand its product line and enhance its offerings while targeting new markets for growth. Specific geographic expansions are in development, but concrete regions and timelines have not been disclosed.

## Funding rounds

- Series B, Feb 25, 2022, $10M — DSM Venturing, StartGreen Capital, Calm/Storm Ventures
- Series A, Oct 31, 2019, $8.9M — Monkfish Equity, Blossom, Tona Investments LP, Spark Invest
- Seed, Jul 7, 2017 — Monkfish Equity

## Investors

- Monkfish Equity (https://capitalatlas.ai/funds/monkfish-equity) — Seed, Series A
- Blossom (https://capitalatlas.ai/funds/blossom) — Series A
- Tona Investments LP — Series A
- Spark Invest — Series A
- DSM Venturing (https://capitalatlas.ai/funds/dsm-venturing) — Series B
- StartGreen Capital (https://capitalatlas.ai/funds/startgreen-capital) — Series B
- Calm/Storm Ventures (https://capitalatlas.ai/funds/calm-storm-ventures) — Series B
